StephenKFrankelMD
Pulmonology • Denver, COCritical Care Medicine, Pleural Disease
Associate Professor, Medicine, University of Colorado School of Medicine
Dr. Frankel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 Jackson St
Denver, CO 80206Phone+1 303-398-1528Fax+1 303-270-2206
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1998 - 2001
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1998
Harvard Medical SchoolClass of 1995
Certifications & Licensure
CO State Medical License 1998 - 2025
NY State Medical License 2015 - 2020
AZ State Medical License 2014 - 2017
NV State Medical License 2014 - 2017
WY State Medical License 2013 - 2017
AK State Medical License 2015 - 2016
NE State Medical License 2014 - 2016- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellow (FCCM) American College of Critical Care Medicine
Clinical Trials
- Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure Start of enrollment: 2011 Mar 10
Publications & Presentations
PubMed
- 5 citationsThe Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity.Haolin Liu, Pengcheng Wei, Katja Aviszus, Qianqian Zhang, Jared Linderberger
International Journal of Molecular Sciences. 2022-09-26 - 24 citationsThe Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccinesHaolin Liu, Pengcheng Wei, Qianqian Zhang, Katja Aviszus, Jared Linderberger
Biorxiv. 2021-08-26 - 40 citations501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitroHaolin Liu, Pengcheng Wei, Qianqian Zhang, Zhongzhou Chen, Katja Aviszus
Biorxiv. 2021-02-16
Press Mentions
The U.S. Physician Shortage Is Only Going to Get Worse. Here Are Potential SolutionsJuly 25th, 2022- Health for the People: Past, Current, and Future Contributions of National Community Health Worker Programs to Achieving Global Health GoalsApril 5th, 2021
Two Denver Hospitals Start in-House COVID-19 Testing, Results in 24 Hours Rather Than DaysMarch 23rd, 2020
Grant Support
- Death Receptors, P53 And AKT In Myofibroblast Apoptosis.National Heart, Lung, And Blood Institute2003–2007
- Death Receptors Of P53 In Myofibroblast ApoptosisNational Heart, Lung, And Blood Institute2002
Professional Memberships
- Fellow
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
